Fast track development of a Zika vaccine based on measles vector

Project Information

ZIKAVAX

Grant agreement ID: 732432

DOI 10.3030/732432

Project closed

EC signature date 2 December 2016

Start date 1 October 2016

End date 31 December 2020

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 4 918 137,50

EU contribution € 4 918 137,50

Coordinated by

EUROPEAN VACCINE INITIATIVE EWIV
Germany

Deliverables

Websites, patent fillings, videos etc. (1)

Launch of the website

Website launched

Intellectual Property Rights

Patent (1)

RECOMBINANT MEASLES VIRUS EXPRESSING ZIKA VIRUS PROTEINS AND THEIR APPLICATIONS

Application/Publication number: 18 731021
Date: 2018-06-06